1. Home
  2. GAB vs TXG Comparison

GAB vs TXG Comparison

Compare GAB & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAB
  • TXG
  • Stock Information
  • Founded
  • GAB 1986
  • TXG 2012
  • Country
  • GAB United States
  • TXG United States
  • Employees
  • GAB N/A
  • TXG N/A
  • Industry
  • GAB Investment Managers
  • TXG Biotechnology: Laboratory Analytical Instruments
  • Sector
  • GAB Finance
  • TXG Industrials
  • Exchange
  • GAB Nasdaq
  • TXG Nasdaq
  • Market Cap
  • GAB 1.9B
  • TXG 1.6B
  • IPO Year
  • GAB N/A
  • TXG 2019
  • Fundamental
  • Price
  • GAB $5.93
  • TXG $11.82
  • Analyst Decision
  • GAB
  • TXG Buy
  • Analyst Count
  • GAB 0
  • TXG 12
  • Target Price
  • GAB N/A
  • TXG $13.54
  • AVG Volume (30 Days)
  • GAB 667.8K
  • TXG 2.5M
  • Earning Date
  • GAB 01-01-0001
  • TXG 11-06-2025
  • Dividend Yield
  • GAB 10.91%
  • TXG N/A
  • EPS Growth
  • GAB N/A
  • TXG N/A
  • EPS
  • GAB N/A
  • TXG N/A
  • Revenue
  • GAB N/A
  • TXG $644,466,000.00
  • Revenue This Year
  • GAB N/A
  • TXG $2.11
  • Revenue Next Year
  • GAB N/A
  • TXG N/A
  • P/E Ratio
  • GAB N/A
  • TXG N/A
  • Revenue Growth
  • GAB N/A
  • TXG 2.02
  • 52 Week Low
  • GAB $4.56
  • TXG $6.78
  • 52 Week High
  • GAB $5.88
  • TXG $18.21
  • Technical
  • Relative Strength Index (RSI)
  • GAB 39.19
  • TXG 46.26
  • Support Level
  • GAB $5.87
  • TXG $11.17
  • Resistance Level
  • GAB $6.05
  • TXG $12.66
  • Average True Range (ATR)
  • GAB 0.08
  • TXG 0.62
  • MACD
  • GAB -0.02
  • TXG 0.04
  • Stochastic Oscillator
  • GAB 19.05
  • TXG 36.34

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: